Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
OneCell Diagnostics Inc. | $16,000,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
Certified by Founder
Lodge
MOSTLY AI
start up
Austria
- Vienna, Wien
- 11/01/2022
- Series B
- $25,000,000
MOSTLY AI pioneered the creation of synthetic data for AI model development and software testing. MOSTLY AI’s synthetic data sets look just as real as a company’s original customer data with just as many details, but without the original personal data points – thus helping companies comply with privacy protection regulations such as GDPR, and ensuring models are fair and unbiased. The fast-growing company currently works with multiple Fortune 100 banks and insurers in North America and Europe, and has the deepest expertise in helping companies get business value out of synthetic data.
- Industry IT Services and IT Consulting
- Website https://mostly.ai/
- LinkedIn https://www.linkedin.com/company/mostlyai/
Enveda | $130,000,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
DANNCE.ai | $2,600,000 | (Nov 22, 2024)
Trustero | $10,000,000 | (Nov 22, 2024)
Dote | $1,447,585 | (Nov 22, 2024)
CredFlow | $3,700,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
Faircraft | $15,800,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)